Comparative activity of sulbactam and sulbactam/durlobactam against carbapenem-resistant A. baumannii isolates producing OXA-23 or OXA-23 plus PER-1 enzymes
Hasan Cenk Mirza, Aylin Üsküdar Güçlü, Sezin Ünlü, Süleyman Yalçın · 2026
Read Comparative activity of sulbactam and sulbactam/durlobactam against carbapenem-resistant A. baumannii isolates producing OXA-23 or OXA-23 plus PER-1 enzymes by Hasan Cenk Mirza, Aylin Üsküdar Güçlü, Sezin Ünlü, Süleyman Yalçın (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7153077790.txt.
Description
Hasan Cenk Mirza led a 2026 study in the Journal of Antibiotics testing two drug options against Acinetobacter baumannii, a hospital bacterium that resists carbapenems, some of the strongest antibiotics. The team compared sulbactam alone with sulbactam joined with durlobactam, a partner drug that shields it from bacterial enzymes. Twenty-four resistant isolates carrying specific resistance genes were tested in the laboratory.
Almost all isolates were susceptible to the combination, while only one reacted to sulbactam alone. The two isolates that resisted the combination carried changes in a target protein gene, and one also lacked a brake on a pump that expels drugs. The authors conclude that the combination keeps working well against these strains, with resistance tracing to changes that can be pinpointed.
Catalog record
| CREATOR | Hasan Cenk Mirza, Aylin Üsküdar Güçlü, Sezin Ünlü, Süleyman Yalçın |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / The Journal of Antibiotics |